How MomMetabolic makes money

When you follow one of our outbound provider links and sign up, MomMetabolic may receive a referral fee from that provider. It costs you nothing extra — your price is the same as if you had found the provider directly. Not every provider we cover pays us, and we do not label which do, because the safest assumption for you as a reader is to treat every outbound link as one that could earn us a fee. That is the honest default, and it is the one we ask you to hold.

Here is the line that matters most. A referral fee has no route into a Metabolic-Fit Score. Scores come out of a fixed, published rubric — six factors weighted for mothers — applied the same way to a provider that pays us and one that never will. There is no line item, no multiplier, no thumb on the scale. A provider that scores poorly is ranked poorly whether or not there is a commercial relationship.

What money can influence is visibility: a homepage spotlight, a featured card, or which topics we write about first. Wherever placement is shaped by a commercial relationship, we disclose it at that spot.

In the running order it buys placement, and that is worth being precise about. On the ranking table and the best-of boards we list the providers we earn from first, then everyone else, each group in Metabolic-Fit Score order. It buys nothing else: not the score, not the six factors, not a word of the write-up. The score is printed next to every row, so the order can be weighed against it — and our #1 pick holds the top score on the evidence, with or without the placement.

For the record, that means providers we earn nothing from currently sit at #34 and above several of our partners. We would rather publish that than a ranking you cannot audit.

Referral revenue funds the actual work: reading FDA labels and trial literature, re-checking provider pricing (which drifts constantly in this market), maintaining the review system, and keeping every guide free with no paywall. It does not buy a higher score for anyone, and it never will.

MomMetabolic is an independent publisher. We are not a pharmacy, a telehealth company, or a medical provider, and we are not owned by or affiliated with any provider or drug maker beyond ordinary referral agreements. We do not review the whole market — the providers we cover reflect our editorial priorities and the women's-health questions our readers actually bring us.

Our rankings are a research starting point, not medical advice, and never a recommendation to take a specific medication. Compounded GLP-1 products are not FDA-approved finished drugs, and GLP-1 medicines are not used in pregnancy or while trying to conceive. Prices, availability, and regulatory status change quickly — confirm current details on the provider's own site, and read our medical disclaimer before acting on anything here.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S; Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. We name them only to identify the medications under discussion; doing so implies no endorsement or affiliation, and MomMetabolic is not connected to any manufacturer.

Questions about how we're funded? The contact details are on our about page.